# First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

> **NCT02339207** · PHASE1 · COMPLETED · sponsor: **Alios Biopharma Inc.** · enrollment: 112 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** AL-335 matching placebo
- **DRUG:** AL-335

## Key facts

- **NCT ID:** NCT02339207
- **Lead sponsor:** Alios Biopharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-31
- **Primary completion:** 2016-05-31
- **Final completion:** 2016-05-31
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2019-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02339207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02339207, "First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02339207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*